The client is a publicly traded, international biotechnology company. The company specializes in the creation and development of differentiated antibody therapies for cancer.
The company chose Infosys as their partner for SAP S/4HANA implementation. The objective of the engagement was to build a solid ERP platform that would support rapid commercial growth and deliver the capabilities for modern user experience and consolidated financial reporting.
Key Challenges
Ready to experience?
TALK TO EXPERTS
Infosys implemented a digital transformation initiative, leveraging the core capabilities of SAP S/4HANA. The program covered the following processes and functions at the client’s global locations:
The digital transformation program was aimed at designing and implementing a digital ERP platform with standardized business processes, while adopting SAP and industry best practices. The key objective was to maximize effectiveness, minimize cost, and provide a competitive advantage to the company. The Infosys team achieved this by implementing an integrated solution with key internal and external applications. This improved both reporting and decision-making.
Digital integrated ERP platform for future business growth
Process optimization and standardization across the business
Significant reduction in financial closure time during month-end and quarter-end financial closure cycles
Easier reporting with excellent user experience and real-time analytical reports, using SAP Fiori
Increased operational efficiency through integration and automation with bank and suppliers
Validated environment that fulfils SOX compliance and various other regulatory requirements